Zomedica Pharmaceuticals Corp. (ZOM.V) (CVE:ZOM) Stock Price Down 6.6% – Here’s Why

Zomedica Pharmaceuticals Corp. (ZOM.V) (CVE:ZOM)’s stock price dropped 6.6% during mid-day trading on Monday . The company traded as low as C$0.29 and last traded at C$0.29. Approximately 4,800 shares traded hands during mid-day trading, an increase of 68% from the average daily volume of 2,858 shares. The stock had previously closed at C$0.31.

Zomedica Pharmaceuticals Corp. (ZOM.V) Trading Down 6.6 %

The company has a current ratio of 15.31, a quick ratio of 15.25 and a debt-to-equity ratio of 4.91. The firm has a 50-day moving average of C$0.29 and a 200 day moving average of C$0.28. The company has a market cap of C$36.73 million and a P/E ratio of -2.61.

About Zomedica Pharmaceuticals Corp. (ZOM.V)

Zomedica Pharmaceuticals Corp., a development stage veterinary diagnostic and pharmaceutical company, engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. Its lead drug product candidate is ZM-007, an oral suspension formulation of metronidazole for the treatment of acute diarrhea in small dog breeds and puppies.